173 related articles for article (PubMed ID: 36381574)
1. tRNA-derived fragment tRF-1001: A novel anti-angiogenic factor in pathological ocular angiogenesis.
Jiang Q; Ma Y; Zhao Y; Yao MD; Zhu Y; Zhang QY; Yan B
Mol Ther Nucleic Acids; 2022 Dec; 30():407-420. PubMed ID: 36381574
[TBL] [Abstract][Full Text] [Related]
2. Transfer RNA derived fragment, tRF-Glu-CTC, aggravates the development of neovascular age-related macular degeneration.
Liang Y; Kong L; Zhang Y; Zhang Y; Shi M; Huang J; Kong H; Qi S; Yang Y; Hong J; Zhu M; Zhu X; Sun X; Zhang S; Wu L; Zhao C
Theranostics; 2024; 14(4):1500-1516. PubMed ID: 38389841
[No Abstract] [Full Text] [Related]
3. Targeting choroidal vasculopathy via up-regulation of tRNA-derived fragment tRF-22 expression for controlling progression of myopia.
Liu C; Li M; Shen Y; Han X; Wei R; Wang Y; Xu S; Zhou X
J Transl Med; 2023 Jun; 21(1):412. PubMed ID: 37355654
[TBL] [Abstract][Full Text] [Related]
4. tRF-1001: A potential therapeutic target for ocular neovascular diseases.
Cingaram PR
Mol Ther Nucleic Acids; 2023 Mar; 31():293-294. PubMed ID: 36959836
[No Abstract] [Full Text] [Related]
5. tRNA-derived fragment tRF-1020 ameliorates diabetes-induced retinal microvascular complications.
Ma C; Du J; Ma X
J Cell Mol Med; 2022 Oct; 26(20):5257-5266. PubMed ID: 36128646
[TBL] [Abstract][Full Text] [Related]
6. Endothelial TWIST1 promotes pathological ocular angiogenesis.
Li J; Liu CH; Sun Y; Gong Y; Fu Z; Evans LP; Tian KT; Juan AM; Hurst CG; Mammoto A; Chen J
Invest Ophthalmol Vis Sci; 2014 Nov; 55(12):8267-77. PubMed ID: 25414194
[TBL] [Abstract][Full Text] [Related]
7. A Novel tRNA-Derived Fragment, tRF
Chen Q; Shen L; Liao T; Qiu Y; Lei Y; Wang X; Chen L; Zhao Y; Niu L; Wang Y; Zhang S; Zhu L; Gan M
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37833999
[TBL] [Abstract][Full Text] [Related]
8. A novel tRNA-derived fragment tRF-3022b modulates cell apoptosis and M2 macrophage polarization via binding to cytokines in colorectal cancer.
Lu S; Wei X; Tao L; Dong D; Hu W; Zhang Q; Tao Y; Yu C; Sun D; Cheng H
J Hematol Oncol; 2022 Dec; 15(1):176. PubMed ID: 36527118
[TBL] [Abstract][Full Text] [Related]
9. Targeting circular RNA-MET for anti-angiogenesis treatment via inhibiting endothelial tip cell specialization.
Yao MD; Jiang Q; Ma Y; Zhu Y; Zhang QY; Shi ZH; Zhao C; Yan B
Mol Ther; 2022 Mar; 30(3):1252-1264. PubMed ID: 34999209
[TBL] [Abstract][Full Text] [Related]
10. microRNA-181a inhibits ocular neovascularization by interfering with vascular endothelial growth factor expression.
Yang C; Tahiri H; Cai C; Gu M; Gagnon C; Hardy P
Cardiovasc Ther; 2018 Jun; 36(3):e12329. PubMed ID: 29608244
[TBL] [Abstract][Full Text] [Related]
11. COCO/DAND5 inhibits developmental and pathological ocular angiogenesis.
Popovic N; Hooker E; Barabino A; Flamier A; Provost F; Buscarlet M; Bernier G; Larrivée B
EMBO Mol Med; 2021 Mar; 13(3):e12005. PubMed ID: 33587337
[TBL] [Abstract][Full Text] [Related]
12. Exosome-mediated delivery of an anti-angiogenic peptide inhibits pathological retinal angiogenesis.
Dong X; Lei Y; Yu Z; Wang T; Liu Y; Han G; Zhang X; Li Y; Song Y; Xu H; Du M; Yin H; Wang X; Yan H
Theranostics; 2021; 11(11):5107-5126. PubMed ID: 33859737
[No Abstract] [Full Text] [Related]
13. Succinate-induced macrophage polarization and RBP4 secretion promote vascular sprouting in ocular neovascularization.
Shen T; Lin R; Hu C; Yu D; Ren C; Li T; Zhu M; Wan Z; Su T; Wu Y; Cai W; Yu J
J Neuroinflammation; 2023 Dec; 20(1):308. PubMed ID: 38129891
[TBL] [Abstract][Full Text] [Related]
14. Pathogenic role and therapeutic potential of pleiotrophin in mouse models of ocular vascular disease.
Wang W; LeBlanc ME; Chen X; Chen P; Ji Y; Brewer M; Tian H; Spring SR; Webster KA; Li W
Angiogenesis; 2017 Nov; 20(4):479-492. PubMed ID: 28447229
[TBL] [Abstract][Full Text] [Related]
15. SCF (Stem Cell Factor) and cKIT Modulate Pathological Ocular Neovascularization.
Kim KL; Seo S; Kim JT; Kim J; Kim W; Yeo Y; Sung JH; Park SG; Suh W
Arterioscler Thromb Vasc Biol; 2019 Oct; 39(10):2120-2131. PubMed ID: 31434494
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-145 Regulates Pathological Retinal Angiogenesis by Suppression of TMOD3.
Liu CH; Wang Z; Huang S; Sun Y; Chen J
Mol Ther Nucleic Acids; 2019 Jun; 16():335-347. PubMed ID: 30981984
[TBL] [Abstract][Full Text] [Related]
17. tRNA-derived fragments (tRFs) regulate post-transcriptional gene expression via AGO-dependent mechanism in IL-1β stimulated chondrocytes.
Green JA; Ansari MY; Ball HC; Haqqi TM
Osteoarthritis Cartilage; 2020 Aug; 28(8):1102-1110. PubMed ID: 32407895
[TBL] [Abstract][Full Text] [Related]
18. Protective roles of tRNA-derived small RNA tRF-Ile-AAT-019 in pathological progression of psoriasis.
Zeng J; Xie Y; Zhang H; Zhang Y; Zhang Y; Liu L; Hu Q; Zhou L; Gao L; Tan W; Fu Z; Lu J
Exp Dermatol; 2023 Feb; 32(2):135-145. PubMed ID: 36251463
[TBL] [Abstract][Full Text] [Related]
19. Hyperglycemia-regulated tRNA-derived fragment tRF-3001a propels neurovascular dysfunction in diabetic mice.
Zhu JY; Yao W; Ni XS; Yao MD; Bai W; Yang TJ; Zhang ZR; Li XM; Jiang Q; Yan B
Cell Rep Med; 2023 Oct; 4(10):101209. PubMed ID: 37757825
[TBL] [Abstract][Full Text] [Related]
20. A novel tRNA-derived fragment AS-tDR-007333 promotes the malignancy of NSCLC via the HSPB1/MED29 and ELK4/MED29 axes.
Yang W; Gao K; Qian Y; Huang Y; Xiang Q; Chen C; Chen Q; Wang Y; Fang F; He Q; Chen S; Xiong J; Chen Y; Xie N; Zheng D; Zhai R
J Hematol Oncol; 2022 May; 15(1):53. PubMed ID: 35526007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
